LENZ Therapeutics, Inc.
NASDAQ:LENZBiotechnology
Healthcare
$3.34 -6.62%
-$0.42 today
- Market cap
- $104.94M
- Beta
- 1.47
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$3.48
52W Low $5.85High $50.40
Volume 0.64M
Average 0.89M
Price history
LENZ Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-87.95%
Period high
$31.94
Period low
$3.01
Latest
$3.34
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G | Nov 4, 2026 | Nov 4, 2026 | |
| 10-Q | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 2, 2026 | Nov 2, 2026 | |
| SC 13D/A | Nov 2, 2026 | Nov 2, 2026 | |
| 8-K | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| SC 13G/A | Oct 21, 2026 | Oct 21, 2026 | |
| SC 13G/A | Sep 8, 2026 | Sep 8, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Jul 2, 2026 | Jul 2, 2026 | |
| SC 13G | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 15, 2026 | Jun 15, 2026 |
Competitors
Who does LENZ Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about LENZ's filings, answered from its disclosures.
What is the latest LENZ filing?
The latest filing shown is SC 13G/A dated Nov 5, 2026.
How many recent filings does LENZ have?
Intrinsic Alpha currently shows 20 recent filings for LENZ.
Continue the stock analysis
Jump to another research area for this company.